FGA antibody (AA 139-784)
Quick Overview for FGA antibody (AA 139-784) (ABIN7600004)
Target
See all FGA AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 139-784
 - 
                                            
Purpose
 - Anti-Fibrinogen alpha chain/FGA Antibody Picoband®
 - 
                                            
Cross-Reactivity (Details)
 - No cross-reactivity with other proteins.
 - 
                                            
Characteristics
 - Anti-Fibrinogen alpha chain/FGA Antibody Picoband® (ABIN7600004). Tested in ELISA, Flow Cytometry, WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
 - 
                                            
Purification
 - Immunogen affinity purified.
 - 
                                            
Immunogen
 - E.coli-derived human Fibrinogen alpha chain/FGA recombinant protein (Position: E139-Q784).
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - 
                        Western blot, 0.25-0.5 μg/mL, Human
Immunohistochemistry (Paraffin-embedded Section), 0.5-1 μg/mL, Human
Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human
ELISA, 0.1-0.5 μg/mL, -
1. Ahn, H. J., Glickman, J. F., Poon, K. L., Zamolodchikov, D., Jno-Charles, O. C., Norris, E. H., Strickland, S. A novel A-beta-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice. J. Exp. Med. 211: 1049-1062, 2014. 2. Akassoglou, K., Yu, W.-M., Akpinar, P., Strickland, S. Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron 33: 861-875, 2002. 3. Alving, B. M., Henschen, A. H. Fibrinogen Giessen I: a congenital homozygously expressed dysfibrinogenemia with A-alpha arg-to-his substitution. Am. J. Hemat. 25: 479-482, 1987. - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Reconstitution
 - Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
 - 
                                            
Concentration
 - 500 μg/mL
 - 
                                            
Buffer
 - Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.
 - 
                                            
Preservative
 - Sodium azide
 - 
                                            
Precaution of Use
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Storage
 - 4 °C,-20 °C
 - 
                                            
Storage Comment
 - 
                        Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. 
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles. 
 - 
                                            
 - 
    
- FGA (Fibrinogen alpha Chain (FGA))
 - 
                                            
Alternative Name
 - FGA
 - 
                                            
Background
 - 
                        
Synonyms: Fibrinogen alpha chain, FGA
Tissue Specificity: Detected in blood plasma (at protein level).
Background: Fibrinogen alpha chain?is a?protein?that in humans is encoded by the?FGA?gene. This gene encodes the alpha subunit of the coagulation factor fibrinogen, which is a component of the blood clot. Following vascular injury, the encoded preproprotein is proteolytically processed by thrombin during the conversion of fibrinogen to fibrin. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing.
 - 
                                            
Molecular Weight
 - 95 kDa
 - 
                                            
Gene ID
 - 2243
 - 
                                            
UniProt
 - P02671
 
Target
 -